	Impact of Distinct Molecular and Immunological Features of Breast Cancer on the Effectiveness of Therapies in Ghana. Breast Cancer (Auckl) Essilfie NK, Abakah A, Etsey M, Ofori-Amanfo D, Boampong K, Gyan BA, Kashala OL, Kwarteng EVS, Andam-Akorful SA, Paintsil V, Kwarteng A, Larbi AA. PMID: 42186480 [PubMed]
	Invasive lobular carcinoma: Shining a light on the second most prevalent type of breast cancer. Nurse Pract Csaky WL, Coombe AH, Kruse M. PMID: 42186108 [PubMed - indexed for MEDLINE]
	Overall survival and long-term safety of olaparib maintenance in patients with platinum-sensitive relapsed ovarian cancer: final analyses of phase III L-MOCA trial. J Ovarian Res Liu X, Liu D, Peng Z, Zhu J, Zhao W, Huang Y, An R, Zheng H, Qu P, Wang L, Zhou Q, Wang D, Lou G, Wang J, Low J, Kong B, Yin R, Xie X, Liu J, Sun W, Zang R, Ma D, Gao Q. PMID: 42186031 [PubMed - as supplied by publisher]
	STAT1 and STAT3 signaling in ovarian cancer: prognostic biomarkers and therapeutic targets. BMC Cancer Rodman EPB, Bhagwate A, Smith HM, Emch MJ, Pearson NA, Sun Z, Hawse JR. PMID: 42186004 [PubMed - as supplied by publisher]
	Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer. BMC Med Imaging Kahraman EG, Unal OU, Taskaynatan H, Ozdemir O, Budak E, Selver MA. PMID: 42185986 [PubMed - as supplied by publisher]
	Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies. Breast Cancer Res Servitja S, Carrasco E, Andrés R, Rodríguez-Lescure Á, Martín M, Ruiz-Borrego M, Guerrero Á, Bermejo B, Antón A, Muñoz M, Margeli M, Álvarez I, Fernández LA, Ponce J, Cruz J, Martínez P, López-Tarruella S, Amenedo M, Blasco A, Polonio Ó, Gil-Gil M. PMID: 42185928 [PubMed - as supplied by publisher]
	Neighborhood Socioeconomic Deprivation and Perceived Discrimination Among Endometrial Cancer Survivors. Psychooncology Brown JA, Martin CL, Roberson ML, Bey GS, Anderson C, Peterson M, Hunter J, Smith S, Black-Grant S, Bae-Jump VL, Olshan AF, Nichols HB. PMID: 42185225 [PubMed - indexed for MEDLINE]
	Integrative co-delivery platforms for paclitaxel: Advancing synergistic breast cancer therapy. Biomed Pharmacother Almalki WH. PMID: 42184759 [PubMed - as supplied by publisher]
	Integrative multi-omics and network analysis identify potential targets of Chaihu Shugan Xiaozheng Formula in breast cancer. Transl Oncol Luo T, Xue M, Du Y, Chen H, Sun Y, Sun H. PMID: 42184719 [PubMed - as supplied by publisher]
	Can CCR2+ non-classical monocytes serve as a diagnostic biomarker in HER2-negative breast cancer? A pilot study. Cytokine Budzy, Kubicka A, Kycler W, Za, Brzezi, Grupi. PMID: 42184695 [PubMed - as supplied by publisher]
	CT-derived body composition and clinical outcomes in ovarian cancer patients: A scoping review. Eur J Surg Oncol Ohm N, Møller Andersen M, Oreskov JO, Høgdall C, Henrichsen Schnack T. PMID: 42184663 [PubMed - as supplied by publisher]
	A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes. Rev Esp Patol Krishnappa A, Kanakapura Paramesh H, Suresh R, Prashantha K, Vivek HK, Narasaraju TA. PMID: 42184620 [PubMed - as supplied by publisher]
	Challenges and outcomes of breast reconstruction in advanced-stage breast cancer: a comprehensive review. Cir Cir Barajas-Garcia MZ, Hernández-Sánchez EN, Ayala-Andrade MM, Bucheli-Villalobos A, Valdez-Perea DA, Espinoza-Ortiz LP, Jauregui-Gelviz AC, Galicia-Marín MA, Tiburcio-Jiménez D. PMID: 42184403 [PubMed - indexed for MEDLINE]
	Post-operative acute pain assessment and management in breast cancer patients: a best practice implementation project. JBI Evid Implement Zhong X, Tang H, Wu C, Zhang L, Chen W, Li Q, Ou Q, Xu H. PMID: 42184243 [PubMed - as supplied by publisher]
	An Adaptive Fusion Network for Breast Tumor Grading Based on Graph Structure Learning. IEEE J Biomed Health Inform Yang L, Li K, Yu Z, Jiang Y, Han S, Zhao X, Gao J, Jiang H, Ma L. PMID: 42184189 [PubMed - as supplied by publisher]
	Datopotamab deruxtecan for endocrine-resistant HR-positive/HER2-negative breast cancer: biological rationale and clinical evidence. Naunyn Schmiedebergs Arch Pharmacol Gumma B, Gumma L. PMID: 42183859 [PubMed - as supplied by publisher]
	Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy. J Radiat Res Sarsitthithum T, Nantavithya C, Lertbutsayanukul C, Saksornchai K. PMID: 42183732 [PubMed - as supplied by publisher]
	Breast Cancer Burden in BRICS Countries Attributable to Smoking, High Alcohol Use, High Body Mass Index, and Low Physical Activity, 1990-2021: Findings from the Global Burden of Disease 2021 and Mendelian Randomization. Int J Womens Health Yan X, Liao C, Qian S, Zhang C, Wu J, Fang J, Zhao X, Peng L. PMID: 42183404 [PubMed]
	Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management. Front Immunol Shao M, Wang T, Ji L, Xu L, Zhang Y, Wang D, Jia C, Chen L, Zhang H, Yan W, Cui X, Tong R. PMID: 42183263 [PubMed - indexed for MEDLINE]
	Development and validation of a TLS-associated signature for prognosis prediction in breast cancer: new insights into QPRT. Front Immunol Li Q, Yang X, Wei L, Wang X, Wang X, Chen J, Zhao L, Wen S. PMID: 42183191 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 329196

Page 1 of 16460



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy